| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.2 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.3 |